CCL2 and neoplasm: Immunochemistry of tumor tissues harvested earlier also confirmed that the group with PDPN(+) CAFs expressed higher levels of PDPN, CCL2, and p‐AKT in the tumor stroma compared to the PDPN(−) CAFs group and NC group (Figure S3A).